B. Barón

Clinical determinants of survival in patients with 5-fluorouracil- based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients

C.-H. Köhne, David Cunningham, Francesco Di Costanzo et al. · Annals of Oncology · 2002 · 458 citations · Full text

Medicine, Biostatistics, Oncology +12

Chemotherapy Alone as Initial Treatment for Primary CNS Lymphoma in Patients Older Than 60 Years: A Multicenter Phase II Study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group

Khê Hoang‐Xuan, Luc Taillandier, Olivier Chinot et al. · Journal of Clinical Oncology · 2003 · 263 citations

Medicine, Oncology, Pharmacology +15

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972

Martin J. van den Bent, Olivier Chinot, Willem Boogerd et al. · Annals of Oncology · 2003 · 166 citations · Full text

Medicine, Oncology, Pharmacology +12

Randomized Phase III Study of High-Dose Fluorouracil Given As a Weekly 24-Hour Infusion With or Without Leucovorin Versus Bolus Fluorouracil Plus Leucovorin in Advanced Colorectal Cancer: European Organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952

C-H Köhne, J. Wils, M. Lorenz et al. · Journal of Clinical Oncology · 2003 · 160 citations

Medicine, Oncology, Pharmacology +14

A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial

Michel Ducreux, Eric Van Cutsem, Jean‐Luc Van Laethem et al. · European Journal of Cancer · 2005 · 129 citations

Medicine, Oncology, Pharmacotherapy +9